Update README.md
Browse files
README.md
CHANGED
|
@@ -1,3 +1,53 @@
|
|
| 1 |
---
|
| 2 |
license: mit
|
| 3 |
---
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
---
|
| 2 |
license: mit
|
| 3 |
---
|
| 4 |
+
# Data Card: DILGOM Whole-Blood Microarray Dataset (E-TABM-1036)
|
| 5 |
+
|
| 6 |
+
## Summary
|
| 7 |
+
|
| 8 |
+
Expression + sample metadata + feature metadata for E-TABM-1036, which
|
| 9 |
+
profile whole-blood gene expression in a population-based cohort from
|
| 10 |
+
the Helsinki/Vantaa area of Finland. Profiled on Illumina HumanHT-12 v3
|
| 11 |
+
Expression BeadChip. This accession has **no obesity or metabolic-syndrome
|
| 12 |
+
phenotype data**. These are the 'healthy' controls.
|
| 13 |
+
|
| 14 |
+
## Source accession
|
| 15 |
+
|
| 16 |
+
| Accession | N (SDRF rows) | Platform | Submitter |
|
| 17 |
+
|---|---|---|---|
|
| 18 |
+
| [E-TABM-1036](https://www.ebi.ac.uk/biostudies/arrayexpress/studies/E-TABM-1036) | 518 | Illumina HumanHT-12 v3 | Inouye (Wellcome Trust Sanger Institute) |
|
| 19 |
+
|
| 20 |
+
|
| 21 |
+
## Files
|
| 22 |
+
|
| 23 |
+
- `sample_metadata.parquet` — one row per sample: `sample_id`, `accession`, `age_band`, `sex`.
|
| 24 |
+
This is the full extent of usable per-sample metadata in the SDRF — see Notes.
|
| 25 |
+
- `feature_metadata.parquet` — one row per probe (`IlluminaID`): annotation from
|
| 26 |
+
`illuminaHumanv3.db` (`SYMBOL`, `ENTREZID`, `ENSEMBL`, `GENENAME`, `UNIPROT`) plus
|
| 27 |
+
reannotation QC fields from the package's internal `ExtraInfo` table (`ProbeQuality`,
|
| 28 |
+
`CodingZone`, `GenomicLocation`, `SecondMatches`, `OtherGenomicMatches`, `RepeatMask`,
|
| 29 |
+
`OverlappingSNP`, `ProbeSequence`)
|
| 30 |
+
- `expression/` — partitioned parquet dataset (by `accession`, for schema consistency with
|
| 31 |
+
other datasets in this collection even though there is only one accession here),
|
| 32 |
+
long format: `IlluminaID`, `sample_id`, `accession`, `value`
|
| 33 |
+
|
| 34 |
+
## Expression value processing (from the accession's IDF)
|
| 35 |
+
|
| 36 |
+
Per the submitter's own protocol description (`bioassay_data_transformation`
|
| 37 |
+
protocol, P-TABM-5309):
|
| 38 |
+
|
| 39 |
+
> *"Normalized intensities were calculated via quantile normalization of
|
| 40 |
+
> the weighted-sums of the raw replicate intensities. Weighting was by
|
| 41 |
+
> number of beads contributing to raw signal. Final intensities were
|
| 42 |
+
> arrived at by a log2 transformation after quantile normalization."*
|
| 43 |
+
|
| 44 |
+
RNA source: PAXgene Blood RNA Tubes, whole blood (per protocol
|
| 45 |
+
P-TABM-5305), amplified via in vitro transcription (P-TABM-5306) and
|
| 46 |
+
hybridized to HumanHT-12 v3 BeadChips (P-TABM-5307).
|
| 47 |
+
|
| 48 |
+
|
| 49 |
+
## Provenance / reproducibility
|
| 50 |
+
|
| 51 |
+
Data retrieved with `ArrayExpress::getAE()` against BioStudies (EBI), with
|
| 52 |
+
probe annotation from Bioconductor's `illuminaHumanv3.db`. See
|
| 53 |
+
[pull_dilgom.R](pull_dilgom.R)
|